SCHEMBL4701060

SCHEMBL4701060

Cc1cc(F)ccc1Oc1ccccc1C1(O)CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
HDAC2 Q92769 2/20 0.40
HDAC1 Q13547 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
TACR1 P25103 1/20 0.39
SYK P43405 1/20 0.38
TSHR P16473 2/20 0.38
GPR119 Q8TDV5 2/20 0.38
ALOX15 P16050 1/20 0.38
ATM Q13315 1/20 0.38
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
RORC P51449 1/20 0.37
S1PR2 O95136 1/20 0.37
BRD3 Q15059 1/20 0.37
USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4789410 0.91 HTR1A (0.42) PDK2L3MBTL1HDAC1MEN1KMT2A
SCHEMBL4702942 0.88 APP (0.44) PDK2L3MBTL1TSHRS1PR2
SCHEMBL4702045 0.88 L3MBTL1 (0.56) PDK2L3MBTL1TSHR
SCHEMBL6002487 0.86 OPRM1 (0.40) L3MBTL1
SCHEMBL4704779 0.81 GPR119 (0.44) PDK2L3MBTL1HDAC1KMT2ATSHR
SCHEMBL6160222 0.80 OPRM1 (0.53) PDK2HDAC1TSHRGPR119ALOX15
SCHEMBL3249913 0.80 OPRD1 (0.49) PDK2L3MBTL1HDAC1TACR1TSHR
SCHEMBL4702930 0.80 L3MBTL1 (0.44) PDK2L3MBTL1MEN1KMT2ATSHR
SCHEMBL3783489 0.79 PDK2 (0.48) PDK2HDAC1MEN1KMT2ATACR1
SCHEMBL1513609 0.79 HDAC2 (0.45) PDK2L3MBTL1HDAC2HDAC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635828-B1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS LUNDBECK & CO AS H (DK) 2008-04-23 EP disclosed
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors H. LUNDBECK A/S (DK) 2006-12-28 US disclosed
EP-1635828-A1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. Lundbeck A/S (DK) 2006-03-22 EP disclosed
WO-2004087155-A1 4-(2-PHENYLOXYPHENYL)-PIPERIDINE OR -1,2,3,6-TETRAHYDROPYRIDINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS H. LUNDBECK A/S (DK) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293360-A1 4-(2-Phenyloxyphenyl)-piperidine or-1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors HTR1D, TPH1, HTR2C PDK2 206/4885L3MBTL1 4442/4885HDAC2 275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.